However, a reduction in insulin sensitivity is associated with uncontrolled acromegaly [31]; therefore, it has been suggested that initiating antidiabetic medications that improve insulin sensitivity, such as metformin, may also be an effective strategy for managing pasireotide LAR-associated hyperglycemia in patients with acromegaly [32]. This evidence concerns the gene INS and acromegaly.